MUMBAI, May 8, 2007 -Ahmedabad-based biopharmaceutical major Intas Biopharmaceuticals Limited (IBPL) and Viropro Inc. (Viropro) signed a Memorandum of Understanding (MoU) to jointly explore the possibilities of production of an undisclosed molecule. The MoU offers unique collaboration opportunities to both the companies for commercial as well as research interests. With this development, IBPL is looking forward to invest equity in Viropro.
